Position in AXGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,607,827
+$2,569,664 QoQ
Shares Held
78,715
+6650.9% QoQ
Ownership
0.148%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
10 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in AXGN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Aquatic Capital Management LLC holds $80,413,064 across 23 Medical Devices names. AXGN ranks #5 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
490,622 | $30,786,530 | |
| 2 | ABT |
Abbott Laboratories
|
271,681 | $27,893,488 | |
| 3 | PEN |
Penumbra Inc
|
25,975 | $8,529,410 | |
| 4 | PODD |
Insulet Corp
|
21,068 | $4,420,909 | |
| 5 | AXGN |
Axogen, Inc.
This page
|
78,715 | $2,607,827 | |
| 6 | SNN |
Smith & Nephew PLC
|
34,875 | $1,108,327 | |
| 7 | BFLY |
Butterfly Network, Inc.
|
226,243 | $914,021 | |
| 8 | CLPT |
ClearPoint Neuro, Inc.
|
89,677 | $816,060 |
All Filings in AXGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,607,827 | 78,715 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $38,163 | 1,166 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $30,506 | 1,710 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,784 | 441 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $414,733 | 22,418 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $201,385 | 12,220 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $671,558 | 47,900 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $51,404 | 7,100 | Shares | Sole | 2024-08-14 | |
| 2022-12-31 | $87,824 | 8,800 | Shares | Sole | 2023-02-14 | |
| 2021-12-31 | $3,748 | 400 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||